Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rahul Seth

Plastic Surgery within the Head & Neck Walnut Creek, CA Medical Doctor

NPI 1073784682 CMS profile 140201

355 Lennon Ln Ste 235, Walnut Creek, CA 94598

Open in the dashboard

General payments

$31,745

52 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$30,986 paid to institutions, not to them · program year 2021

Through program year 2025, Rahul Seth of Walnut Creek, CA is reported in the CMS Open Payments database as having received $31,745 across 52 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $30,986 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Plastic Surgery within the Head & Neck profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $123 4
2024 General $301 3
2023 General $20,052 23
2022 General $8,994 10
2021 General $1,381 6
2020 General $565 3
2019 General $329 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rahul Seth
  • Plastic Surgery within the Head & Neck median
  • Middle half of Plastic Surgery within the Head & Neck
  • National median

In program year 2025, general payments to Rahul Seth were reported at $123. Among 399 Plastic Surgery within the Head & Neck profiles paid that year, the median was $237 and the middle half received between $103 and $520.

Show as a table
Year Rahul Seth Plastic Surgery within the Head & Neck median Middle half National median
2019 $329 $200 $82–$550 $163
2020 $565 $120 $46–$330 $114
2021 $1,381 $166 $60–$382 $132
2022 $8,994 $208 $83–$530 $149
2023 $20,052 $202 $77–$538 $160
2024 $301 $260 $99–$645 $164
2025 $123 $237 $103–$520 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $16,237 19 payments
  2. Allergan Inc. $8,791 9 payments
  3. Synthes GmbH $5,787 10 payments
  4. Stryker Corporation $340 7 payments
  5. Kerecis Limited $202 1 payment
  6. Vioptix Inc $152 1 payment
  7. Celgene Corporation $78 1 payment
  8. AxoGen $65 1 payment
  9. PolarityTE, Inc. $50 1 payment
  10. Merz North America, Inc. $22 1 payment
  11. Other $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $22,100 2 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $3,750 5 payments
  3. Travel and Lodging $3,335 7 payments
  4. Food and Beverage $2,060 36 payments
  5. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $500 2 payments
Products named General payments · program years 2019–2025
  1. BOTOX $8,942 16 payments
  2. Kerecis Omega3 SurgiClose $202 1 payment
  3. Kerecis Omega3 Marigen Wound Care $202 1 payment
  4. Kerecis Omega3 Marigen Wound Care $202 1 payment
  5. Kerecis Omega3 Marigen Wound Care $202 1 payment
  6. Kerecis Omega3 Marigen Wound Care $202 1 payment
  7. T. Ox Oximeter $152 1 payment
  8. MEDICAL MODELS $145 1 payment
  9. N/A $81 2 payments
  10. Avance Nerve Graft $65 1 payment
  11. Other $319 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

53

Median for Otolaryngology: 297

Drug cost

$312

Median for Otolaryngology: $6,314

Branded share of claims

43.4%

Median for Otolaryngology: 10.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $162
Cephalexin Generic 30 $150

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$59,222

Medicare's payments for the services billed

Medicare patients

79

Average age 70

Services billed

1,521

50 women, 29 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 61%
Arthritis 39%
Chronic kidney disease 23%
Osteoporosis 23%
Diabetes 22%
Depression 20%
Ischemic heart disease 19%
Heart failure 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

52 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery within the Head & Neck in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record